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To est blish cut8off v lues for s liv ry LC8MS/MS cortisol  nd cortisone in defining
 dequ te  drenocortic l function during  st nd rd syn cthen test.
Methods
We comp red s liv ry LC8MS/MS cortisol  nd cortisone responses to those of serum 
cortisol me sured on the Roche E170 immuno ss y  n lyser  nd the Abbot Architect
i2000 before  nd 30 minutes  nd 60 minutes following 0.25mg of intr venous
syn cthen.
Results
Correl tion of s liv ry cortisol  nd cortisone were bimod l  nd line r respectively.
B sed on these correl tions,  dequ te s liv ry cortisol  nd cortisone responses to
syn cthen were extr pol ted from  serum cortisol (Roche) cut8off of 550 nmol/L  nd
defined  s 15 nmol/L  nd 45nmol/L respectively. The Abbott method correl ted well
with the Roche but g ve results th t were  bout 20% lower th n the Roche method.
Conclusions
Me surement of s liv ry cortisol  nd cortisone responses offer  n  ltern tive to those
of serum cortisol during  syn cthen test in the investig tion of  dren l hypofunction.
2Annals of Clinical Biochemistry 





             
          
              
               
            
            
 
 
          
          
           
             
           
            
          
             
             
          
           
    
 
            
           
            
           
             
    
 
            
            
          
































































Cortisol circul tes  s free cortisol (<5%) but mostly bound to the c rrier proteins
cortisol binding globulin (CBG)  nd  lbumin. Serum cortisol, however, is  
me surement of free  nd bound cortisol  nd in conditions of  ltered CBG levels, such
 s  cute illness or oestrogen ther py, it m y be misle ding  s it does not  ccur tely
reflect serum free cortisol. Cortisol in s liv , however,  ccur tely reflects serum free
cortisol  s it is unbound  nd in equilibrium with circul ting free cortisol [183].
Cortisol in the s liv ry gl nds is de ctiv ted by 11β8hydroxysteroid dehydrogen se
type 2 (11β8HSD2) to cortisone. S liv ry cortisol concentr tions  re, therefore,
dependent upon circul ting free cortisol  nd its met bolism by s liv ry 11β8HSD2 to
cortisone. Circul ting free  nd bound cortisone  re st ble in their b s l st te  nd
following  dren l stimul tion  nd therefore their contribution to s liv ry cortisone is
const nt [183]. Incre ses in s liv ry cortisone  re, therefore, solely due to its
conversion from s liv ry cortisol by 11β8HSD2. This indic tes th t s liv ry cortisol
 nd cortisone m y be better biom rkers of  dren l function th n serum cortisol. The
low s liv ry cortisone  nd cortisol concentr tions, which  re ten fold  nd thirty fold
lower th n serum tot l cortisol concentr tions respectively, however precluded their
 ccur te  nd reli ble me surement until the  dvent of liquid chrom togr phy t ndem
m ss spectroscopy (LC8MS/MS).
We h ve encountered p tients, referred for syn cthen tests to exclude  dren l f ilure,
who h ve extremely difficult venous  ccess. Multiple  ttempts of often unsuccessful
c nnul tion  re extremely distressing for them. In these p tients  ssessment of
 dren l function using s liv ry cortisol inste d of serum cortisol would circumvent
the problem. There is, however, p ucity of d t on s liv ry LC8MS/MS cortisol  nd
cortisone responses to syn cthen.
We, therefore, comp red s liv ry cortisol  nd cortisone responses to those of serum
cortisol during  st nd rd 0.25mg syn cthen test. Appropri te cut8offs for s liv ry
cortisol  nd cortisone defining  dequ te  drenocortic l function during  syn cthen
test were extr pol ted from widely  ccepted serum cortisol cut off v lues.
3Annals of Clinical Biochemistry 
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Page 4 of 9 
1 
2 
3 Subjects and Methods
4 
Patients
6 In  six month prospective ev lu tion study, outp tients  ttending the endocrine  nd
7 
met bolic dyn mic function clinic for  short syn cthen test for possible  dren l
8 
insufficiency were recruited. Inclusion criteri included those willing to p rticip te9 
who did not h ve periodont l dise se  nd t were not t king or h d not recently
received either oestrogens or glucocorticoids. All p tients h d simult neous blood  nd11 
12 s liv s mples  s det iled below.
13 
14 Short s nacthen test (SST)
Short syn cthen tests were performed in the  fternoon. An intr venous c nnul w s
16 inserted into  n  ntecubit l foss vein  nd b seline blood  nd s liv s mples were
17 
collected between 14.00h  nd 14.30h. Two hundred  nd fifty microgr ms of
18 
Tetr cos ctide (Syn cthen, Alli nce Ph rm ceutic ls Ltd, Chippenh m, UK) w s then19 
 dministered intr venously  nd further blood  nd s liv ry s mples collected 30  nd
60 minutes l ter. Blood  nd s liv s mples were collected into S rstedt serum/z4 gel21 
22 tube (S rstedt S fety Monovette serum Z/4 2, Aktiengesellsch ft & Co, Germ ny)
23  nd S livette tubes (Pl in cotton sw b; S rstedt, Numbrecht, Germ ny) respectively.
24 
Blood w s sep r ted  nd serum cortisol me sured by electrochemiluminescence
26 immuno ss y (Elecsys Cortisol, Roche Di gnostics GmbH, M nnheim, Germ ny) on
27 
the Roche Modul r An lytics E170 immuno ss y  n lyser  nd by  
28 
chemiluminescence microp rticle immuno ss y on  n Abbot Architect i2000 (Abbott29 
L bor tories, USA). S liv ry s mples were centrifuged  t 3000rpm for 5 minutes.
The cotton w s then disc rded  nd the extr cted s liv frozen  t 880C until  n lysis
32 for cortisol  nd cortisone by LC8MSMS. LC8MSMS  n lysis w s performed on  
33 Shim dzu Prominence HPLC system coupled to  n ABSciex 3200 m ss spectrometer
34 b sed on  previously described method [4,5]. The only differences were the use of
phenomenex C8 gu rd c rtridges (AJO84289) for the solid ph se extr ction steps  nd
31 





The Elecsys Cortisol  ss y h s  detection limit of 2nmol/L (p ck insert; Elecsys
Cortisol, Roche Di gnostics GmbH, M nnheim, Germ ny) with intr 8 ss y  nd inter8 
42  ss y coefficients of v ri tion (cv) of 1.1%  t 418 nmol/L  nd 1.7%  t 410 nmol/L
43 respectively (in8house d t ). The Abbott Architect cortisol  ss y h s  detection limit
44 of 22 nmol/L (p ck insert; Abbott L bor tories, USA) with intr 8 ss y  nd inter8 ss y
cvs of 4.3%  nd 3.2%  t 103 nmol/L  nd 374 nmol/L respectively. Cross re ctivity in
41 
46 the cortisol  ss y due to cortisone is 2.7% for the Abbott Architect (p ck insert;
47 
Abbott L bor tories, USA)  nd 0.3% for the Elecysys (p ck insert; Elecsys Cortisol,
48 
Roche Di gnostics GmbH, M nnheim, Germ ny). Both the LC8MSMS cortisol  nd49 
cortisone  ss ys h ve  detection limit of 0.25 nmol/L. The intr 8 ss y cv for cortisol
51  nd cortisone were 4.9%  t 9.5 nmol/L  nd 4.9%  t 9.5 nmol/L respectively  nd the
52 inter8 ss y cv for cortisol  nd cortisone were 10.8%  t 9.7 nmol/L  nd 6.0%  t 10
53 nmol/L respectively (in8house d t ).
54 
A norm l cortisol response to syn cthen w s defined  s  post8stimul tion pe k Roche
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Thirty8six p tients (16 fem le) with  me n  ge 51y (r nge 15888) were studied. Of
6 these 32 p tients h d norm l (NR)  nd four p tients h d  bnorm l (AR) serum 
7 
cortisol responses to syn cthen  s defined by the cut off for the Roche method.
8 
9 
The medi n, lower limit  nd upper limit of  n lytes  ccording to method for the 32
NR  nd four AR  re shown in T ble 1. The Abbott method g ve results th t were11 
12  bout 20% lower th n the Roche method. S liv ry cortisone concentr tions were
13  pproxim tely 3 fold higher th n the equiv lent s liv ry cortisol concentr tions.
14 
Correl tion of s liv ry cortisol with the Roche serum cortisol w s bimod l,
16 intersecting  t the CBG s tur tion level of  serum cortisol of 600nmol/L (y =
17 2 2
0.0214x – 2.0105 R =0.6037 <600nmol/L; y = 0.0852x – 42.666 R =0.6836
18 
>600nmol/L)  s shown in Figure 1. Correl tion of s liv ry cortisone with the Roche19 2
serum cortisol (Figure 2) w s line r (y = 1.072x – 13.939 R =0.7511) with minim l
pivot  round the CBG s tur tion point. B sed on these correl tions,  dequ te s liv ry21 
22 cortisol  nd cortisone responses to syn cthen were extr pol ted from  serum cortisol
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We used  LCMSMS method for the  n lysis of s liv ry cortisol  nd cortisone b sed
upon  previously described robust method [4,5] to f cilit te the investig tion of
 dren l disorders. The  dv nt ges of s liv ry cortisol  n lysis over blood cortisol
 n lysis in the investig tion of Cushing’s syndrome  re well8recognised. These
include more  ccur te reflection of biologic lly  ctive free pl sm cortisol, non8 
inv siveness, stress free for the p tient, no risk of needle stick injury  nd e se of
collection  llowing potenti l home testing  nd posting of s mples. Less well8 
recognised  re the potenti l benefits of s liv ry  n lysis over blood  n lysis in
investig ting  dren l hypofunction including those p tients with either difficult
venous  ccess  nd/or  ltered CBG concentr tions.
S liv ry cortisol h d  bimod l correl tion with serum cortisol, which is consistent
with previous reports [1,3]. The r pid incre se in s liv ry cortisol  t serum cortisol
concentr tions gre ter th n 600nmol/L, suggests circul ting CBG is s tur ted with
cortisol  t  serum cortisol concentr tion of 600 nmol/L [3]. Comp red to s liv ry
cortisol, s liv ry cortisone concentr tions were threefold higher  nd h d  closer
line r correl tion with serum cortisol. S liv ry cortisol concentr tions  re dependent
not only on circul ting free cortisol but  lso on its met bolism by s liv ry 11β8HSD2
to cortisone, where s ch nges in s liv ry cortisone concentr tions  re solely due to its
conversion from s liv ry cortisol since  dren l stimul tion does not  ffect circul ting
cortisone levels [2,3]. These d t suggest th t s liv ry cortisone m y be the preferred
 n lyte in the  ssessment for  dren l function.
Abbott serum cortisol results were 20% lower th n Roche serum cortisol results,
which is well8recognised [6]  nd evident from EQA schemes. This h s, therefore, led
to the concept of  ss y specific cut8offs for defining norm l serum cortisol responses
to syn cthen [6,8]. V ri bility in immuno ss y  nd non8immuno ss y perform nce
indic tes th t LC8MSMS s liv ry cortisol cut8offs defined in this study m y not be
tr nsfer ble to s liv ry cortisol immuno ss ys.
There  re insufficient d t to define reference interv ls for s liv ry cortisol  nd
cortisone. Cut8off v lues of 15nmol/L for s liv ry cortisol  nd 45nmol/L for s liv ry
cortisone were, therefore, extr pol ted from est blished serum cut8off cortisol v lue
of 550 nmol/L  nd would h ve correctly cl ssified  ll p tients into those with norm l
 nd those  bnorm l responses to syn cthen. Cortisol responses to intr muscul r
syn cthen  re simil r to those following intr venous syn cthen [7]. We, therefore,
pl n to offer syn cthen tests with s liv ry cortisol  nd cortisone me surement for
suspected  dren l hypofunction routinely in p tients with limited venous  ccess  nd
those with suspected  ltered CBG concentr tions .
6Annals of Clinical Biochemistry 
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arch 30, 2015 
Time
(mi s)
Serum Roche  mol/L Serum Abbott  mol/L Sal Cortisol  mol/L Sal Cortiso e  mol/L
NR (32 AR (4 NR (32 AR (4 NR (32 AR (4 NR (32 AR (4 
Media 
n








LL UL Media 
n
LL UL Media 
n
LL UL Media 
n
LL UL Media 
n
LL UL Media 
n
LL UL
0 412 14 751 112.5 11 19 329.1 115.5 600.38 89.58 8.38 157.9 3.445 1.0 9.2 1.022 0.66 2.6 21.1 8.7 48. 5.185 0.50 14. 
5 8 8 8 8 4 2 3 3 3 2 2 8
30 699 46 124 266.5 27 43 558.7 367.5 992.38 212.7 21.1 349.1 15.6 7.3 57. 4.24 0.32 6.8 52 28. 184 16.05 1 17. 
0 1 7 8 8 8 8 8 4 1 6 2 5 3
60 798.5 55 133 328.5 34 53 638.3 441.9 1069.9 262.3 26.7 424.3 27.1 14. 86 5.1 0.28 10. 77.9 38. 144 18.4 1.25 28. 
3 8 1 8 8 8 8 8 8 1 6 9 2





Serum Cortisol (Roche) 550
Serum Cortisol (Abbott) 440
*Salivary cortisol 15
*Salivary cortiso e 45
Table 2 Cut-off values for defining adequate adrenal function during a 0.25mg synacthen test.
*Corresponding to serum cortisol cut-offs derived from salivary cortisol/cortisone correlations with serum cortisol
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- 3. 382 
y = 0. 45x -
0 500  000 







- 2.0 05 
= 0.6037 
y = 0.0852x -
0 500  000 
Salivary Cortisol low end 




y = .02 4x
 0 
0 
 500 - 0 
Figur 1 Salivary Cortisol vs S rum cortisol (nmol/L)





Salivary Cortisone low end 





Figur 2 Salivary Cortison vs S rum cortisol (nmol/L)
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